Asia-Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region
Lao, Zhentang, Tse, Eric Wai Choi, Chuncharunee, Suporn, Kwong, Yok Lam, Wei, Andrew, Ko, Bor Sheng, Kim, Jin Seok, Ng, Soo Chin, Wang, Jianxiang, Goh, Yeow Tee
Published in Asia-Pacific journal of clinical oncology (01.12.2023)
Published in Asia-Pacific journal of clinical oncology (01.12.2023)
Get full text
Journal Article
Poster: AML-457 Oral Azacitidine (Oral-AZA) in Patients With Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial
Ravandi, Farhad, Wei, Andrew H., Döhner, Hartmut, Sayar, Hamid, Montesinos, Pau, Dombret, Hervé, Selleslag, Dominik, Porkka, Kimmo, Jang, Jun Ho, Skikne, Barry, Beach, C.L., Tian, Yu (Olivia), Roboz, Gail J.
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
AML-457 Oral Azacitidine (Oral-AZA) in Patients With Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial
Ravandi, Farhad, Wei, Andrew H., Döhner, Hartmut, Sayar, Hamid, Montesinos, Pau, Dombret, Hervé, Selleslag, Dominik, Porkka, Kimmo, Jang, Jun Ho, Skikne, Barry, Beach, C.L., Tian, Yu (Olivia), Roboz, Gail J.
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1, GATA2 and DDX41
Brown, Anna L., Homan, Claire, Drazer, Michael W., Yu, Kai, Lawrence, David, Feng, Jinghua, Arriola-Martinez, Luis, Pozsgai, Matthew, McNeely, Kelsey, Ha, Thuong, Venugopal, Parvathy, Arts, Peer, King-Smith, Sarah, Cheah, Jesse JC, Armstrong, Mark, Bödör, Csaba, Wang, Paul, Cantor, Alan B., Cazzola, Mario, Degelman, Erin, DiNardo, Courtney D., Duployez, Nicolas, Favier, Remi, Fröhling, Stefan, Rio-Machin, Ana, Klco, Jeffery M., Krämer, Alwin, Kurokawa, Mineo, Lee, Joanne, Malcovati, Luca, Morgan, Neil V, Natsoulis, Georges, Owen, Carolyn, Patel, Keyur P., Preudhomme, Claude, Raslova, Hana, Rienhoff, Hugh Young, Ripperger, Tim, Schulte, Rachael, Tawana, Kiran, Velloso, Elvira Deolinda Rodrigues Pereira, Yan, Benedict, Sood, Raman, Hsu, Amy, Holland, Steven M., Phillips, Kerry, Poplawski, Nicola, Babic, Milena, Kwon Kim, Erika M, Wei, Andrew H., Forsyth, Cecily, Mar Fan, Helen, Lewis, Ian D, Cooney, Julian, Susman, Rachel, Fox, Lucy C, Blombery, Piers, Singhal, Deepak, Hiwase, Devendra, Schreiber, Andreas W, Hahn, Christopher N, Scott, Hamish S, Liu, Paul P., Godley, Lucy A.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Post-Allogeneic Stem Cell Transplant Surveillance of CD34+ Sorted Peripheral Blood to Quantify Emergent DNMT3A, IDH and NPM1 clones and Correlation with Clinical Outcome
Fleming, Shaun, Cummings, Nik, Das, Tongted, Ivey, Adam, McManus, Julie, Avery, Sharon, Patil, Sushrut S., Walker, Patricia A., Curtis, David J., Spencer, Andrew, Wei, Andrew
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study
Wei, Andrew, Ribera, Josep-Maria, Martinelli, Giovanni, Larson, Richard A., Ritchie, David, Ghobadi, Armin, Chen, Yuqi, Dos Santos, Cedric E., Zimmerman, Zachary F., Kantarjian, Hagop M.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse: Results from the phase III QUAZAR AML-001 maintenance trial
Dohner, Hartmut, Wei, Andrew, Montesinos, Pau, Dombret, Hervé, Ravandi, Farhad, Sayar, Hamid, Porkka, Kimmo, Sandhu, Irwindeep, Passamonti, Francesco, Pane, Fabrizio, Robak, Tadeusz, Falantes, Jose F., Schuh, Andre C., Ossenkoppele, Gert J., La Torre, Ignazia, Skikne, Barry, Kumar, Keshava, Dong, Qian, Beach, C. L., Roboz, Gail J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A phase III study of venetoclax plus low-dose cytarabine in previously untreated older patients with acute myeloid leukemia (VIALE-C): A six-month update
Wei, Andrew H., Montesinos, Pau, Ivanov, Vladimir, Dinardo, Courtney Denton, Novak, Jan, Laribi, Kamel, Kim, Inho, Stevens, Don A., Fiedler, Walter M., Pagoni, Maria, Samoilova, Olga, Wang, Jianxiang, Anagnostopoulos, Achilles, Bergeron, Julie, Hou, Jing-Zhou, Yamauchi, Takahiro, Jiang, Qi, Mendes, Wellington, Hayslip, John W., Panayiotidis, Panayiotis
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Health-related quality of life (HRQoL) in the phase III QUAZAR-AML-001 trial of CC-486 as maintenance therapy for patients with acute myeloid leukemia (AML) in first remission following induction chemotherapy (IC)
Roboz, Gail J., Dohner, Hartmut, Pocock, Christopher, Dombret, Hervé, Ravandi, Farhad, Jang, Jun Ho, Selleslag, Dominik, Mayer, Jiri, Martens, Uwe Marc, Liesveld, Jane, del Castillo, Teresa Bernal, Wang, Ming-Chung, La Torre, Ignazia, Skikne, Barry, Kumar, Keshava, Dong, Qian, Braverman, Julia, Abi Nehme, Salem, Beach, C. L., Wei, Andrew
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (≥75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: Results from the phase III QUAZAR AML-001 trial
Ravandi, Farhad, Wei, Andrew, Dohner, Hartmut, Dombret, Hervé, Ossenkoppele, Gert J., Pfeilstöcker, Michael, Thol, Felicitas, Feldman, Georg, Voso, Maria Teresa, Marlton, Paula, Harvey, Michael, Santini, Valeria, Fianchi, Luana, Candoni, Anna, La Torre, Ignazia, Skikne, Barry, Kumar, Keshava, Dong, Qian, Beach, C. L., Roboz, Gail J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Estimating the Productivity Impact of Acute Myeloid Leukemia in Australia Between 2020 and 2029, Using a Novel Work Utility Measure: The Productivity-Adjusted Life Year (PALY)
Parker, Catriona, Liew, Danny, Ademi, Zanfina, Owen, Alice J, Ayton, Darshini, Wei, Andrew, Zomer, Ella
Published in JCO oncology practice (01.11.2021)
Published in JCO oncology practice (01.11.2021)
Get more information
Journal Article
Venetoclax with Low-Dose Cytarabine Induces Rapid, Deep, and Durable Responses in Previously Untreated Older Adults with AML Ineligible for Intensive Chemotherapy
Wei, Andrew, Strickland, Stephen A., Hou, Jing-Zhou, Fiedler, Walter, Lin, Tara L, Walter, Roland B., Enjeti, Anoop K, Hong, Wan-Jen, Chyla, Brenda, Popovic, Relja, Fakouhi, Kaffa, Xu, Tu, Hayslip, John, Roboz, Gail J.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity in AML
Salmon, Jessica M, Pomilio, Giovanna, Moujalled, Donia M, Macraild, Sarah, Teh, Charis E, Riajl, Sewa, Ivey, Adam, Teh, Tse-Chieh, Ekert, Paul G, Kraus-Berthier, Laurence, Kloos, Ioana, Schoumacher, Marie, Gray, Daniel, Wei, Andrew H
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Venetoclax in Combination with Hypomethylating Agents Induces Rapid, Deep, and Durable Responses in Patients with AML Ineligible for Intensive Therapy
Pollyea, Daniel A, Pratz, Keith W., Jonas, Brian A., Letai, Anthony, Pullarkat, Vinod A., Wei, Andrew, Konopleva, Marina Y., Recher, Christian, Frankfurt, Olga, Rizzieri, David, Xu, Tu, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, DiNardo, Courtney D.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Identification of Potent BH3-Mimetic Combinations Targeting Pro-Survival Pathways in Human B-Cell Acute Lymphoblastic Leukemia
Moujalled, Donia M, Hanna, Diane T, Pomilio, Giovanna, Litalien, Veronique, Fleming, Shaun, Chanrion, Marie, Maragno, Ana-Leticia, Kraus-Berthier, Laurence, Khaw, Seong Lin, Lessene, Guillaume, Huang, David, Roberts, Andrew W., Geneste, Olivier, Ekert, Paul G, Ng, Ashley P, Wei, Andrew H
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Molecular Patterns of Response and Outcome in the Chemotherapy and Venetoclax in Elderly AML Trial (CAVEAT study)
Wei, Andrew H, Chua, Chong Chyn, Tiong, Ing S, Fong, Chun Yew, Ting, Stephen B, Macraild, Sarah, Salmon, Jessica M, Ivey, Adam, Nguyen, John, Yuen, Flora, Hall, Richard, Fleming, Shaun, Bohlander, Stefan K., Reynolds, John, Roberts, Andrew W.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)
Wei, Andrew H, Kennedy, Glen A, Morris, Kirk L, Grigg, Andrew, He, Simon, Schwarer, Anthony, Ting, Stephen B, Enjeti, Anoop Kumar, Yuen, Sam, D'Rozario, James, Latimer, Maya, Marlton, Paula, Bilmon, Ian, Taper, John, Cull, Gavin, Tiley, Campbell, Verner, Emma, Hahn, Uwe H, Hiwase, Devendra K, Iland, Harry, Murphy, Nichloas, Ravanathan, Sundra, Nguyen, Uyen, Ong, Doen Ming, Loo, Sun, Tiong, Ing-Soo, Wall, Meaghan, Anstee, Natasha S, Levis, Mark, Murray, Michael, Rawling, Tristan, Leadbetter, Joanna, Bajel, Ashish, Roberts, Andrew W
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Panobinostat in combination with azacitidine reduces the frequency of TNFR2+ regulatory T cells in acute myeloid leukemia patients. (P2048)
Govindaraj, Chindu, Tan, Peter, Wei, Andrew, Spencer, Andrew, Plebanski, Magdalena
Published in The Journal of immunology (1950) (01.05.2013)
Published in The Journal of immunology (1950) (01.05.2013)
Get full text
Journal Article